COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PostScript

Letter

COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis

Free

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

	Abstract	Full	Pdf
Sep 2022	611	600	37
Oct 2022	1001	91	11
Nov 2022	848	19	6
Dec 2022	542	28	16
Jan 2023	566	17	15
Feb 2023	230	2	1
Mar 2023	232	13	9
Apr 2023	191	6	1
May 2023	184	7	7
Jun 2023	162	6	3
Jul 2023	168	10	5
Aug 2023	2326	39	13
Sep 2023	1164	485	10
Oct 2023	1185	1179	13
Nov 2023	1027	1025	8
Dec 2023	440	425	9
Jan 2024	581	573	12
Feb 2024	590	582	6
Mar 2024	786	780	12
Total	12834	5887	194